Central Nervous System Pharmacology Practice Questions

Q: Magnesium sulfate is contraindicated in which of the following conditions?

Myasthenia gravis. **Explanation:** **1. Why Myasthenia Gravis is the Correct Answer:** Magnesium sulfate ($MgSO_4$) acts as a neuromuscular blocking agent by inhibiting the release of acetylcholine (ACh) from the presynaptic nerve terminals and decreasing the sensitivity of the motor endplate to ACh. In **Myasthenia Gravis**, there is already a functional deficiency of ACh receptors due to autoantibodies. Administering $MgSO_4$ can precipitate a **myasthenic crisis** or severe respiratory paralysis by further weakening neuromuscular transmission. Therefore, it is strictly contraindicated. **2. Analysis of Incorrect Options:** * **Placenta Previa:** $MgSO_4$ is not contraindicated here. In fact, if a patient with placenta previa requires preterm delivery (before 32 weeks), $MgSO_4$ may be used for fetal neuroprotection. * **Preeclampsia:** This is the **primary indication** for $MgSO_4$. It is the drug of choice for preventing seizures in preeclampsia and controlling seizures in eclampsia (Pritchard or Zuspan regimens). * **Epilepsy:** While $MgSO_4$ is not the standard treatment for chronic epilepsy, it is not contraindicated. However, it is important to distinguish between an eclamptic seizure and an epileptic seizure in a pregnant patient to ensure appropriate anticonvulsant therapy. **3. High-Yield Clinical Pearls for NEET-PG:** * **Absolute Contraindications of $MgSO_4$:** Myasthenia Gravis, Heart Block, and Myocardial Damage. * **Monitoring Parameters:** Always check for **Patellar reflex** (first to disappear), **Respiratory rate** (>12/min), and **Urine output** (>30 ml/hr or 100 ml/4hr) before each dose. * **Therapeutic Range:** 4–7 mEq/L. * **Antidote:** 10 ml of 10% **Calcium Gluconate** IV (administered slowly over 10 minutes). * **Renal Failure:** Since $MgSO_4$ is excreted solely by the kidneys, the dose must be omitted or reduced if urine output is low.

Q: Regarding adverse reactions of anticonvulsants, all are true EXCEPT:

Carbamazepine - Breech presentation. **Explanation:** This question tests knowledge of the teratogenic and systemic adverse effects of common antiepileptic drugs (AEDs). **1. Why Option B is the Correct Answer:** **Carbamazepine** is associated with **Neural Tube Defects (NTDs)**, craniofacial abnormalities, and fingernail hypoplasia. **Breech presentation** is a mechanical obstetric complication related to fetal positioning and is **not** a drug-induced malformation or a recognized adverse effect of Carbamazepine. Therefore, this statement is false. **2. Analysis of Incorrect Options (True Statements):** * **A. Phenobarbitone - Cardiovascular defect:** Phenobarbitone is a known teratogen. Maternal use is associated with congenital heart diseases (e.g., septal defects) and the "Fetal Hydantoin-like Syndrome." * **C. Phenytoin - Gum hyperplasia [1]:** This is a classic, high-yield side effect occurring in about 50% of patients. It is caused by the stimulation of platelet-derived growth factor (PDGF) and fibroblast proliferation. * **D. Sodium valproate - Neural tube defect:** Valproate has the highest teratogenic risk among AEDs. It interferes with folate metabolism, leading specifically to **spina bifida** (incidence ~1-2%). **3. High-Yield Clinical Pearls for NEET-PG:** * **Fetal Hydantoin Syndrome (Phenytoin):** Characterized by cleft lip/palate, microcephaly, and hypoplastic phalanges/nails. * **Valproate:** Most common cause of NTDs; supplementation with high-dose Folic Acid (5mg) is mandatory for women of childbearing age on AEDs. * **Drug of Choice (DOC) in Pregnancy:** **Lamotrigine** and **Levetiracetam** are currently considered the safest AEDs regarding major malformations. * **Enzyme Induction:** Phenytoin, Carbamazepine, and Phenobarbital are potent **CYP450 inducers**, which can lead to Vitamin K deficiency in the neonate (causing hemorrhagic disease of the newborn).

Q: Which one of the following is an indication for valproate?

All of the above. **Explanation:** Valproate (Sodium Valproate/Valproic Acid) is a broad-spectrum anti-epileptic drug with a multifaceted mechanism of action. It increases GABA levels (by inhibiting GABA transaminase), blocks voltage-gated sodium channels, and inhibits T-type calcium channels. This versatility makes it effective across various neurological and psychiatric conditions. * **Option A (Prophylaxis for migraine):** Valproate is a first-line agent for the prophylactic treatment of migraine. It reduces the frequency and severity of attacks, likely by modulating GABAergic neurotransmission and reducing neuronal hyperexcitability. * **Option B (Complex partial seizures):** As a broad-spectrum anticonvulsant, Valproate is effective against almost all seizure types, including generalized (Tonic-clonic, Absence, Myoclonic) and focal seizures (Simple and Complex partial). * **Option C (Acute mania):** Valproate acts as a potent mood stabilizer. It is FDA-approved for the treatment of acute manic or mixed episodes associated with Bipolar Disorder, often showing efficacy in patients who do not respond to Lithium. Since all three clinical scenarios are established indications, **Option D** is the correct answer. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** Valproate is the DOC for **Myoclonic seizures** and is preferred for idiopathic generalized epilepsies. * **Teratogenicity:** It is highly teratogenic, causing **Neural Tube Defects** (e.g., Spina Bifida). Avoid in pregnancy; if essential, supplement with high-dose Folic Acid. * **Side Effects:** Remember the mnemonic **VALPROATE**: **V**omiting, **A**lopecia (curly hair), **L**iver toxicity (Hepatotoxicity), **P**ancreatitis, **R**etention of fat (Weight gain), **O**edema, **A**taxia, **T**hrombocytopenia, and **E**ncephalopathy (due to Hyperammonemia).

Q: Which ester local anesthetic undergoes significant liver metabolism?

Cocaine. **Explanation:** Local anesthetics (LAs) are classified into two groups based on their chemical linkage: **Esters** and **Amides**. The primary metabolic pathway for most ester LAs is rapid hydrolysis by **pseudocholinesterase** (plasma cholinesterase) in the blood. **Why Cocaine is the Correct Answer:** Cocaine is a unique ester local anesthetic. Unlike other esters that are metabolized almost exclusively in the plasma, **Cocaine undergoes significant metabolism in the liver** via carboxylesterase enzymes. While some of it is hydrolyzed by plasma cholinesterase, the hepatic pathway is a major route for its transformation into metabolites like benzoylecgonine (which is excreted in the urine). **Analysis of Incorrect Options:** * **Procaine & Chloroprocaine:** These are classic esters with very short half-lives. They are rapidly and completely hydrolyzed by plasma pseudocholinesterase. Chloroprocaine is the shortest-acting LA due to this rapid metabolism. * **Tetracaine:** A long-acting ester, it is also metabolized by plasma pseudocholinesterase, though at a slower rate than procaine. **NEET-PG High-Yield Pearls:** 1. **Metabolism Rule:** Remember the "i" rule. Am**i**des (Lidocaine, Bupivacaine, Ropivacaine) have two "i"s in their name and are metabolized in the **Liver**. Esters (one "i") are metabolized in the **Plasma**. Cocaine is the notable exception. 2. **Vasoconstriction:** Cocaine is the only local anesthetic that causes **vasoconstriction** by blocking the reuptake of norepinephrine. All other LAs (except to some extent Ropivacaine/Levobupivacaine) are vasodilators. 3. **PABA:** Metabolism of ester LAs produces **para-aminobenzoic acid (PABA)**, which is responsible for the higher incidence of allergic reactions compared to amides.

Q: Amide type of local anesthetic agents undergo biotransformation primarily in which organ?

Liver. **Explanation:** Local anesthetics (LAs) are chemically classified into two categories based on their intermediate chain: **Amides** and **Esters**. The site of metabolism is the fundamental difference between these two groups. **1. Why Liver is Correct:** Amide-type local anesthetics (e.g., Lidocaine, Bupivacaine, Ropivacaine) undergo complex biotransformation primarily in the **liver** via **microsomal P450 enzymes** (specifically N-dealkylation and hydroxylation). Because their clearance depends on hepatic blood flow and enzyme function, patients with liver failure or congestive heart failure are at a higher risk of systemic toxicity (LAST). **2. Why other options are incorrect:** * **Plasma:** This is the primary site for **Ester-type** local anesthetics (e.g., Procaine, Tetracaine, Benzocaine). They are rapidly hydrolyzed by **pseudocholinesterase** (plasma cholinesterase). * **Kidney:** While the kidneys are the primary route for **excretion** of the metabolites, they are not the primary site of metabolism. * **Excreted in unaltered form:** Only a very small fraction (<5%) of local anesthetics is excreted unchanged in the urine. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic:** Amides have two "i"s in their name (L**i**doca**i**ne, Pr**i**loca**i**ne, Bup**i**vaca**i**ne), while Esters have only one (Proca**i**ne, Chloroproca**i**ne). * **Prilocaine Metabolism:** A metabolite of prilocaine (o-toluidine) can cause **methemoglobinemia**, treated with Methylene Blue. * **Rate of Metabolism:** Esters are metabolized much faster than amides, making esters generally less likely to cause systemic toxicity but more likely to cause allergic reactions (due to PABA formation).

Q: Which of the following statements is true regarding carbamazepine?

Used in the treatment of trigeminal neuralgia.. **Explanation:** **Carbamazepine** is a sodium channel blocker that stabilizes hyperexcitable nerve membranes. 1. **Why Option A is Correct:** Carbamazepine is the **drug of choice (DOC) for Trigeminal Neuralgia**. It works by reducing the frequency of paroxysmal discharges in the trigeminal nerve, providing significant pain relief for this specific neuropathic condition. 2. **Analysis of Incorrect Options:** * **Option B:** While Carbamazepine is indeed a potent **enzyme inducer** (inducing CYP3A4 and its own metabolism—autoinduction), the question asks for the "true statement" in a context where Option A is the most clinically definitive primary indication. *Note: In many competitive exams, if multiple statements are technically true, the one defining the drug's primary clinical utility is prioritized.* * **Option C:** Carbamazepine is associated with **aplastic anemia** and agranulocytosis, not megaloblastic anemia. Megaloblastic anemia is a classic side effect of **Phenytoin** (due to folate interference). * **Option D:** The drug of choice for **Status Epilepticus** is intravenous **Lorazepam** (or Diazepam), followed by Fosphenytoin/Phenytoin. Carbamazepine is contraindicated in absence and myoclonic seizures as it may worsen them. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Blocks voltage-gated $Na^+$ channels in the inactivated state. * **DOC for:** Trigeminal neuralgia and Partial (Focal) seizures. * **Side Effects:** Diplopia, Ataxia, **SIADH** (Hyponatremia), and potentially fatal skin reactions like **Stevens-Johnson Syndrome** (associated with the HLA-B*1502 allele). * **Teratogenicity:** Can cause neural tube defects (Spina Bifida).

Q: D2 receptors are maximally seen in which area?

Corpus striatum. **Explanation:** The correct answer is **Corpus striatum**. Dopamine D2 receptors are G-protein coupled receptors (Gi/o) that inhibit adenylyl cyclase. In the brain, they are most densely concentrated in the **Corpus striatum** (comprising the caudate nucleus and putamen). This area is the primary hub of the **Nigrostriatal pathway**, where dopamine is released from the substantia nigra pars compacta to modulate motor control. **Analysis of Options:** * **Corpus striatum (Correct):** It contains the highest density of D2 receptors. This is clinically significant because the blockade of these receptors by antipsychotics (especially first-generation) leads to Extrapyramidal Side Effects (EPS). * **Nucleus accumbens:** While this area is rich in D2 receptors, it is part of the **Mesolimbic pathway** (involved in reward and addiction). The density here is high but remains secondary to the corpus striatum. * **Frontal lobe:** This area is primarily associated with the **Mesocortical pathway**. It contains a higher ratio of D1 and D4 receptors compared to D2. * **Cerebellum:** This region has a very low density of dopamine receptors, as its primary neurotransmitters are GABA and Glutamate. **Clinical Pearls for NEET-PG:** 1. **D2 Blockade:** Antipsychotic potency is directly correlated with their binding affinity for D2 receptors. 2. **Nigrostriatal Pathway:** Blockade here causes EPS (Parkinsonism, Akathisia, Dystonia). 3. **Mesolimbic Pathway:** Blockade here treats the "positive symptoms" of Schizophrenia. 4. **Tuberoinfundibular Pathway:** D2 blockade here leads to hyperprolactinemia (Dopamine is the Prolactin Inhibiting Factor).

Q: Levodopa is contraindicated in which of the following conditions?

Angle closure glaucoma. **Explanation:** **Why Angle Closure Glaucoma is the Correct Answer:** Levodopa is a precursor of dopamine, which is further metabolized into norepinephrine and epinephrine. These catecholamines act on **$\alpha_1$-adrenergic receptors**, causing mydriasis (dilation of the pupil). In patients with a narrow iridocorneal angle, mydriasis can further obstruct the outflow of aqueous humor, leading to a dangerous and acute rise in intraocular pressure (IOP). Therefore, it is strictly contraindicated in **angle-closure (narrow-angle) glaucoma**. However, it can be used cautiously in chronic open-angle glaucoma if IOP is well-controlled. **Analysis of Incorrect Options:** * **A. Hypertension:** While Levodopa can cause transient cardiac arrhythmias or orthostatic hypotension, it is not an absolute contraindication. Blood pressure should be monitored, but it is not a primary contraindication like narrow-angle glaucoma. * **B. Multiple Sclerosis:** This is a demyelinating disease of the CNS. Levodopa has no significant interaction with the pathophysiology of MS and is neither indicated nor contraindicated. * **C. Pheochromocytoma:** While catecholamine-producing tumors require caution with drugs affecting dopamine/norepinephrine, the most definitive and high-yield contraindication among the choices provided for NEET-PG is angle-closure glaucoma. **Clinical Pearls for NEET-PG:** * **Absolute Contraindications of Levodopa:** Angle-closure glaucoma, undiagnosed skin lesions (may activate **malignant melanoma**), and use of **Non-selective MAO inhibitors** (risk of hypertensive crisis). * **Vitamin Interaction:** Pyridoxine (Vitamin B6) increases the peripheral decarboxylation of Levodopa, reducing its CNS availability (unless given with Carbidopa). * **Side Effects:** The "On-Off" phenomenon and dyskinesias are common long-term complications.

Q: Which of the following can be used in the treatment of myoclonic seizures, except?

Carbamazepine. **Explanation:** The correct answer is **Carbamazepine**. **1. Why Carbamazepine is the correct answer:** In the treatment of **Myoclonic seizures**, certain sodium channel blockers like **Carbamazepine**, **Phenytoin**, and **Oxcarbazepine** are strictly contraindicated. These drugs can paradoxically **exacerbate** or worsen myoclonic and absence seizures. The underlying mechanism involves the enhancement of GABA-mediated inhibitory currents in the thalamocortical circuit or the specific blockade of sodium channels that may inadvertently increase the synchrony of neuronal firing in these specific seizure types. **2. Why the other options are incorrect:** * **Valproate (Option A):** This is the **drug of choice** for myoclonic seizures. It has a broad spectrum of activity, affecting sodium channels, T-type calcium channels, and increasing GABA levels. * **Topiramate (Option C):** A broad-spectrum anti-epileptic drug (AED) that is effective against multiple seizure types, including myoclonic seizures, due to its multiple mechanisms (Na+ channel blockade, AMPA/Kainate antagonism, and GABA enhancement). * **Zonisamide (Option D):** Another broad-spectrum agent that is effective in treating myoclonic jerks, particularly in progressive myoclonic epilepsies. **3. High-Yield Clinical Pearls for NEET-PG:** * **Broad-spectrum AEDs** (Valproate, Levetiracetam, Topiramate, Zonisamide, Lamotrigine) are generally safe for myoclonic seizures. * **Narrow-spectrum AEDs** (Carbamazepine, Phenytoin, Gabapentin, Pregabalin, Vigabatrin) should be **avoided** in myoclonic and absence seizures as they can worsen the condition. * **Drug of Choice (DOC) Summary:** * Myoclonic Seizures: **Valproate** * Absence Seizures: **Ethosuximide** (Valproate if generalized tonic-clonic seizures are also present). * Trigeminal Neuralgia: **Carbamazepine**.

Question 1

Magnesium sulfate is contraindicated in which of the following conditions?

Accepted Answer

Myasthenia gravis

Answer

Placenta previa

Answer

Preeclampsia

Answer

Epilepsy

Question 2

Regarding adverse reactions of anticonvulsants, all are true EXCEPT:

Accepted Answer

Carbamazepine - Breech presentation

Answer

Phenobarbitone - Cardiovascular defect

Answer

Phenytoin - Gum hyperplasia

Answer

Sodium valproate - Neural tube defect

Question 3

Which one of the following is an indication for valproate?

Accepted Answer

All of the above

Answer

Prophylaxis for migraine

Answer

Complex partial seizures

Answer

Acute mania

Question 4

Which of the following statements regarding Phenytoin is FALSE?

Accepted Answer

At very low doses, zero-order kinetics occurs

Answer

Induces microsomal enzymes

Answer

Higher the dose, higher is the half-life

Answer

Highly protein-bound

Question 5

Which ester local anesthetic undergoes significant liver metabolism?

Accepted Answer

Cocaine

Answer

Tetracaine

Answer

Procaine

Answer

Chloroprocaine

Question 6

Amide type of local anesthetic agents undergo biotransformation primarily in which organ?

Accepted Answer

Liver

Answer

Kidney

Answer

Plasma

Answer

Excreted in unaltered form

Question 7

Which of the following statements is true regarding carbamazepine?

Accepted Answer

Used in the treatment of trigeminal neuralgia.

Answer

Carbamazepine is a potent enzyme inducer.

Answer

Can cause megaloblastic anemia.

Answer

It is the drug of choice for status epilepticus.

Question 8

D2 receptors are maximally seen in which area?

Accepted Answer

Corpus striatum

Answer

Frontal lobe

Answer

Nucleus accumbens

Answer

Cerebellum

Question 9

Levodopa is contraindicated in which of the following conditions?

Accepted Answer

Angle closure glaucoma

Answer

Hypertension

Answer

Multiple sclerosis

Answer

Pheochromocytoma

Question 10

Which of the following can be used in the treatment of myoclonic seizures, except?

Accepted Answer

Carbamazepine

Answer

Valproate

Answer

Topiramate

Answer

Zonisamide

Central Nervous System Pharmacology — MCQs

Central Nervous System Pharmacology — MCQs

On this page

Practice by Chapter

Want unlimited practice?